On June 23, UBTECH Robotics (09880.HK) fell 3.52% in regular trading, trading at 102.9 HKD/share, with turnover of approximately 2.8 billion HKD.

On the news front, the stock had previously rallied sharply on multiple positive catalysts including the strong pre-sale of its ultra-bionic humanoid robot U1 (nearly 4,000 units reserved, with an official launch scheduled for June 30) and a joint venture with Muxi Semiconductor to establish a chip company. Short-term profit-taking has persisted as gains are unwound. Additionally, concerns over equity dilution from a prior H-share placement at a discount exceeding 11% remain unresolved, with market sentiment continuing to weigh on the stock amid frequent capital-raising activities.

On the fundamental side, despite its status as the leading listed humanoid robotics company, UBTECH remains deep in losses, with cumulative deficits exceeding 5.6 billion RMB over 2020-2025. Revenue grew 53.29% year-over-year to 2.001 billion RMB in 2025, while net losses narrowed 37.42% to 703 million RMB, yet a clear path to profitability has not materialized, sustaining valuation digestion pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)